Review




Structured Review

STEMCELL Technologies Inc lymphoprep gradient separation stem cell cat#07861
Lymphoprep Gradient Separation Stem Cell Cat#07861, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep gradient separation stem cell cat#07861/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep gradient separation stem cell cat#07861 - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

99
TaKaRa lymphoprep stem cell technologies 07851 recombinant rnase inhibitor takara 2313b triton x 100 sigma aldrich t9284 dntp mix
Lymphoprep Stem Cell Technologies 07851 Recombinant Rnase Inhibitor Takara 2313b Triton X 100 Sigma Aldrich T9284 Dntp Mix, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep stem cell technologies 07851 recombinant rnase inhibitor takara 2313b triton x 100 sigma aldrich t9284 dntp mix/product/TaKaRa
Average 99 stars, based on 1 article reviews
lymphoprep stem cell technologies 07851 recombinant rnase inhibitor takara 2313b triton x 100 sigma aldrich t9284 dntp mix - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec cd34 microbeadkit miltenyi biotec 130 056 702 lymphoprep stem cell technologies 7861 ls columns miltenyi biotec
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Cd34 Microbeadkit Miltenyi Biotec 130 056 702 Lymphoprep Stem Cell Technologies 7861 Ls Columns Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd34 microbeadkit miltenyi biotec 130 056 702 lymphoprep stem cell technologies 7861 ls columns miltenyi biotec/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
cd34 microbeadkit miltenyi biotec 130 056 702 lymphoprep stem cell technologies 7861 ls columns miltenyi biotec - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep gradient separation stem cell cat#07861
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep Gradient Separation Stem Cell Cat#07861, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep gradient separation stem cell cat#07861/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep gradient separation stem cell cat#07861 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep stem cell
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep Stem Cell, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep stem cell/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep stem cell - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep (stem cell technology)
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep (Stem Cell Technology), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep (stem cell technology)/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep (stem cell technology) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep stem cell tech cat#07801
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep Stem Cell Tech Cat#07801, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep stem cell tech cat#07801/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep stem cell tech cat#07801 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep (stem cell technology, vancouver, canada)
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep (Stem Cell Technology, Vancouver, Canada), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep (stem cell technology, vancouver, canada)/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep (stem cell technology, vancouver, canada) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep stem cell stem cell catalog # 07801
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep Stem Cell Stem Cell Catalog # 07801, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep stem cell stem cell catalog # 07801/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep stem cell stem cell catalog # 07801 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep stem cell #07861
Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive <t>CD34+CD38</t> HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 <t>CD34+GFP+CBX7-overexpressing</t> or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.
Lymphoprep Stem Cell #07861, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep stem cell #07861/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep stem cell #07861 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive CD34+CD38 HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 CD34+GFP+CBX7-overexpressing or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.

Journal: Cell reports

Article Title: CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions.

doi: 10.1016/j.celrep.2019.01.050

Figure Lengend Snippet: Figure 1. CBX7 Overexpression Induces Enhanced Long-Term Engraftment, Myelopoiesis, and Self-Renewal of Primitive CD34+CD38 HSPCs In Vivo (A) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 200,000 CD34+GFP+CBX7-overexpressing or empty vector (EV) control cord blood cells. (B) Primary recipients were sacrificed after 28–40 weeks, and human engraftment in bone marrow was evaluated. (C) Human chimerism levels in the peripheral blood of NSG mice upon transplantation of 7 days ex vivo-cultured CBX7-overexpressing or empty vector control CD34+ cord blood cells. (D) Human engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplant. (E) Relative engraftment of human CD19+, CD3+, and CD33+ cells within human CD45+GFP+ bone marrow cells of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (F) Human myeloid engraftment in bone marrow of mice shown in (C), combined analysis of mice sacrificed after 18, 22, and 33 weeks post-transplantation. (G) Frequency of CD34+CD38 cells in huCD45+GFP+lin-CD34+ cells in bone marrow of mice shown in (C), 18 combined analysis of mice sacrificed after 18, 22, and 33 weeks post transplantation. Identically colored circles indicate 3 paired experimental and control samples that originate from the same cord. Statistical analysis was performed using a two-tailed Mann-Whitney test.

Article Snippet: N/A Oligonucleotides See Table S8 N/A Software and Algorithms Graphpad Prism (v5-7) Graphpad Prism https://www.graphpad.com ELDA (Hu and Smyth, 2009) http://bioinf.wehi.edu.au/software/elda/ FlowJo Version X.0.7 Other CD34+ MicrobeadKit Miltenyi Biotec 130-056-702 Lymphoprep Stem cell technologies 7861 LS Columns Miltenyi Biotec 130-042-401 e2 Cell Reports 26, 1906–1918.e1–e8, February 12, 2019

Techniques: Over Expression, In Vivo, Transplantation Assay, Plasmid Preparation, Control, Ex Vivo, Cell Culture, Two Tailed Test, MANN-WHITNEY